What's Driving the global legal marijuana market?
February 16, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks, releases its 5th excerpt of its cannabis /hemp stock directory for investors following the sector and provides commentary from Technavio on four key drivers for the industry.
Technavio http://www.technavio.com/ analysts forecast the global legal marijuana market to grow at an astounding CAGR of more than 37% during the forecast period, according to their latest report. Part of the growth is driven by "Rising social acceptance of marijuana , premium pricing due to high energy consumption in marijuana production and growing business opportunities and Increasing business sophistication" according to the report.
They also see technology playing a key role in the growth of the industry. Ujjwal Doshi, a lead media and entertainment services analyst at Technavio, says, "Technological advances in all these operations coupled with the millennial generation's preference for marijuana for recreational purposes is expected to have a huge impact on the market's growth. With the increasing legalization of marijuana during the forecast period, it is important for vendors to engage with their customers, increase the production capacity and to comply with the legality of marijuana use in various countries."
Marijuana/Hemp Stock List 2017
Directory Preview: Get the full list as a member at the Cannabis Directory page: http://www.investorideas.com/Marijuana-Stocks/Stocks_List.asp
Scotts Miracle-Gro Company, The (NYSE:SMG) is the world's largest marketer of branded consumer products for lawn and garden care. The Company's brands are the most recognized in the industry. In the U.S., the Company's Scotts(R), Miracle-Gro(R) and Ortho(R) brands are market-leading in their categories, as is the consumer Roundup(R) brand, which is marketed in North America and most of Europe exclusively by Scotts and owned by Monsanto. In the U.S., we operate Scotts LawnService(R), the second largest residential lawn care service business. In Europe, the Company's brands include Weedol(R), Pathclear(R), Evergreen(R), Levington(R), Miracle-Gro(R) (R), KB(R), Fertiligene(R) and Substral(R).
Signal Bay, Inc. (OTC:SGBY) is an Oregon-based Life Sciences company. Through its three subsidiaries: Signal Bay Research, Signal Bay Services and EVIO Labs; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply.
SINGLEPOINT INC. (OTC:SING) is a full-service mobile technology and marketing provider. We provide solutions that allow our clients to conduct business transactions, accept donations, and engage in targeted communication through mobile devices. SingleSeed - Payment Solutions for the Cannabis Industry
Sipp Industries Inc (OTC:SIPC) is a multifaceted corporation that specializes in technology, manufacturing and distribution of commercial and consumer products. Through its wholly owned subsidiary, Major Hemp, the Company provides high quality and competitively priced hemp based products, bulk hemp, CBD supply, co-packing and private labeling services, including "Major Hemp Brown Ale" brewed by Sleeping Giant Brewing of Colorado
Solis Tek Inc. (OTC:SLTK) is an importer, distributor and marketer of digital lighting equipment for the hydroponics industry with specific focus on the research, design, development and manufacturing of advanced, energy efficient indoor/greenhouse horticulture lighting and ancillary equipment. Using certain of its proprietary technologies, the Company provides innovative aptitudes with its ballast, reflector and lamp products. Our vision is to apply the latest advances in high efficiency lighting and controls technology as well as effective manufacturing techniques to deliver highly differentiated products with clear benefits at competitive prices to the greenhouse and indoor horticulture markets. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad.
Stevia Corp (OTC:STEV) is a farm management company and healthcare company focused on developing highly nutritional, high value products through proprietary plant breeding (including the stevia plant) and hemp, excellent agricultural methodologies and innovative post-harvest techniques. Stevia Corp invests in R&D and IP acquisition and manages its own propagation, nursery and plantations as well as provides services to contract growers and other industry growers. Stevia Corp was founded on the principal of implementing socially responsible, sustainable, quality agribusiness solutions to maximize the long-term efficient production of nutritional crops.
SUPREME PHARMACEUTICALS (CSE:SL; OTC:SPRWF) is a Canadian-owned and operated company whose mission is to enhance the quality of life of our patients and clients by producing sun-grown medical marijuana of the highest standards, quality and value. Supreme Pharmaceuticals Inc. acquired marijuana grow operations in June 2014, with the purchase of Advanced Medical Marijuana Canada ("AMMCan"), a Canadian corporation, which is now a wholly (100%) owned subsidiary and operating as Supreme Medical Marijuana (AMMCAN Supreme). AMMCan Supreme is preapproved by Health Canada to grow produce and distribute 24,000 kilograms of marijuana per annum.
SURNA INC. (OTC:SRNA) develops innovative technologies and products that monitor, control or address the energy and resource intensive nature of indoor cannabis cultivation. Currently, the Company's revenue stream is based on its main product offerings - supplying industrial technology and products to commercial indoor cannabis grow facilities. Headquartered in Boulder, CO, Surna's diverse engineering team is tasked with creating novel energy and resource efficient solutions, including the Company's signature water-cooled climate control platform. The Company's engineers continuously seek to create technology that solve the highly specific demands of the cannabis industry for temperature, humidity, light and process control. Surna's goal is to provide intelligent solutions to improve the quality, the control and the overall yield and efficiency of indoor cannabis cultivation. The Company's operations exclude the production or sale of marijuana.
T-Bird Pharma Inc. (TSX:TPI.V) is the parent company of Thunderbird Biomedical Inc., a wholly owned private subsidiary formed in January, 2013. The principal activities of Thunderbird are the production of marijuana from its Victoria, British Columbia production facility, as regulated by the Marihuana for Medical Purposes Regulations (Canada). Thunderbird obtained a medical marijuana license to undertake the production of medical marijuana in February 2014, being the fifth company in Canada to obtain such a license. Thunderbird was acquired by T-Bird in September, 2013.
TAURIGA SCIENCES INC. (OTC:TAUG) is a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology. The mission of the Company is to acquire and build a diversified portfolio of life science assets that is capital efficient and has the potential to generate meaningful profitable revenues. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Tauriga has developed and is preparing to launch its own proprietary line of cannabis creams under the TopiCanna brand name in the first quarter of 2015. There are two distinct TopiCanna products: one which will contain ingredients to better penetrate to the joints, and one that will contain ingredients that have been successfully used for dermatological conditions. Tauriga's TopiCanna products will be offered in the United States (under compliance with all applicable medical marijuana regulations} as well as in Japan. Medical marijuana law in Japan requires that products use oil that has been extracted from the stalk of the cannabis plant and that is necessarily higher in CBD and low in THC, hence providing wellness and healing properties without psychoactive effects
Terra Tech Corp (OTC: TRTC) through its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. The company integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. Our complete product line is available at specialty retailers throughout the United States, and via our website. TRTC, through its wholly-owned subsidiary, Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Walmart, Krogers, and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, Pennsylvania and the Midwest. The Company's MediFarm LLC subsidiaries are focused on medical cannabis businesses throughout Nevada. IVXX LLC is a wholly-owned subsidiary that produces medical cannabis-extracted products for regulated medical cannabis dispensaries
Tetra BioPharma Inc. (CSE:TBP) formerly GrowPros Cannabis Ventures Inc, is a Canada-based pharmaceutical development company. The Company's principal business is that of medical marijuana consultation and acquisition company, which is engaged in pursuing a license as a producer of medical marijuana in Canada pursuant to Health Canada's Marijuana for Medical Purposes Regulations (MMPR). The Company has operations in Canada.
THC Biomed Intl Ltd. (CSE:THC) is a licensed producer and engaged in the business of developing technologies, products and services to support the Cannabis industry. THC's vision is to be on the leading edge of scientific research, development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.
Therapix Biosciences Ltd. (TASE: THXBY.TA) is an Israeli pharmaceutical company specializing in the development and commercialization of drugs that are based on approved cannabinoid molecules. The Company's product candidates are being developed to treat Tourette syndrome and impairments in cognitive functioning (including preliminary stages of Alzheimer's disease).
Tinley Beverage Company Inc, The (CSE:TNY; OTC:QRSRF) Hemplify, Inc. manufactures the "Hemplify" line of products. "Hemplify" is a line of fruit-flavored, sugar-free, vegan, drinkable supplements that contain hemp stalk extract. This extract contains terpenes and other phytoconstituents. Each product also contains 9-12x the potassium electrolyte content of major sports drinks, 200mg of Omega 3 and excellent sources of 9 vitamins, including 100% DV of Vitamin B12, C and D. Hemplify is produced with patented technology that elevates absorption into the bloodstream, ensures shelf stability and masks the hemp oil's taste to deliver delicious, refreshing flavors. The company is selling its products in California and in 5 other states, as well as online. Hemplify, Inc. (Santa Monica, California) is a wholly-owned subsidiary of The Tinley Beverage Company Inc. (Toronto, Canada). The Tinley Beverage Company has also developed a line of cannabis-infused beverages that it is working to launch in jurisdictions throughout North America where such products are permitted.
Totally Hemp Crazy Inc. (OTC:THCZ) Our mission is to find the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. The Company's products include Hemp Energy Drinks, Lemonade and Iced Teas.
True Leaf Medicine International (CSE:MJ) is entering the $60 billion pet industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada and the US. The company has also filed an application under Health Canada's Marihuana for Medicinal Purposes Regulations (MMPR) to become a Canadian licensed producer. It has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting a 'pre-license inspection' approval.
Tweed Marijuana Inc (TSX:TWD.V) is Canada's first publicly traded medical marijuana company and the first geographically diversified producer with dual licenses under the Health Canada Marihuana for Medical Purposes Regulations. Tweed provides an industry-leading selection of strains to customers who are seeking to treat their symptoms in a reliable, consistent way with a deep commitment and focus on customer care.
TWO RIVERS WATER & FARMING (OTC:TURV) is building a new water paradigm for the arid regions of the southwestern United States. Two Rivers assembles its water assets by acquiring irrigated farmland with senior water rights because 85% of water rights in the arid southwest are owned by agricultural interests. Two Rivers transforms the value of its water rights and farmland by continually developing operations that generate higher revenues and better profit margins. Two Rivers current farm operations convert feed crop farmland into fruit and vegetable crop production in Pueblo County Colorado, which generates six times more revenue with better profit margins. In December 2012, Colorado legalized the personal use and cultivation of marijuana. As a result, Two Rivers is providing greenhouses and processing facilities for licensed marijuana growers in Colorado on land with water rights not used for fruit and vegetable crop production. Two Rivers also develops Metropolitan Districts to serve underserved communities in rural areas in which Two Rivers' farmland and water rights are located. GrowCo Subsidiary: GrowCo was formed for the purpose of constructing state-of-the-art computer-controlled greenhouses for licensed marijuana growers. GrowCo is not a licensed marijuana grower or retailer. GrowCo does not "touch the plant" and only provides growing infrastructure, growing materials and consulting services for licensed marijuana tenants.
United Cannabis Corp (OTC:CNAB) The Company's Prana Bio Medicinal products provide patients a way to mix/match cannabinoids for therapeutic purpose. These products, licensed to regulated marijuana dispensaries, are broken into 5 categories that are available in capsules, sublingual's, and topical delivery methods. The Company uses a patent-pending infusion process utilizing select fatty acids, lipids, and specific combination of cannabis derived terpenes to increase bioavailability.
Valens GroWorks (CSE:GEC) formerly Genovation Capital Corp. - Genovation Capital has acquired Valens Agritech Ltd. by way of a share exchange agreement dated October 31, 2016. Valens is a privately held biotechnology company based in the Okanagan Valley of British Columbia, focused on the cannabis cultivation and research business, with assets and improvements that include a state-of-the-art 17,000 square foot research and development facility in Kelowna. The Company intends to launch a new corporate website at www.valensgroworks.ca
Vape Holdings Inc (OTC:VAPE) focuses on designing, marketing, and distributing various vaporization products. The company offers medical and food grade ceramic products primarily under the HIVE Ceramics brand throughout North America, Europe and South America. HIVE offers a nonporous, non-corrosive, chemically inert ceramic vaporization element, which can be used for a range of applications, including stand-alone vaporization products and electronic cigarettes. The company is based in Agoura Hills, California.
Vapir Enterprises Inc (OTC:VAPI) vaporizer products are intended to integrate elite technology with sophisticated design. We believe that our scientific background may give us the insight necessary to create a cutting-edge convection system that gently massages the active compounds from any herb, flower, or essential oil into a delicious and healthy vapor cloud.
Verde Science (OTC:VRDI) is focused on Medical Research and Development, which includes medical marijuana research and the development of effective treatments for emerging and contemporary health issues that have been inadequately addressed.
VeritasPharma Inc. (CSE:VRT) mission is to develop the most effective cannabis strains for specific disease conditions, and to provide doctors and patients with conclusive scientific evidence to recommend and use medical marijuana with confidence.
VODIS INNOVATIVE PHARMACEUTICALS (CSE:VP) is positioned to be among the first pharmaceutical corporations in Canada to produce and market medical marijuana under license from Health Canada in accordance with the existing Narcotic Control Regulations ("NCR") and the new Marihuana for Medical Purposes Regulations ("MMPR") that came into effect on April 1st, 2014. Vodis filed its MMPR in August of 2013 and in January of 2014 received a ‘ready to build' letter from Health Canada. IT IS CURRENTLY AWAITING FINAL INSPECTION FROM HEALTH CANADA. The company has been operating under the MMAR regulations at its 12,000 square foot production facility, consisting of six rooms. This was recently upgraded to eight rooms, consisting of between 40 and 50 lights per room. The estimated production when fully operational under the MMPR license is between 150-200 pounds per month of award winning cannabis.
WEED INC. (OTC:BUDZ) focuses on purchasing land and building commercial grade cultivation centers for the legal and medical marijuana sector in the United States. The company intends to consult, assist, manage, and lease its cultivation centers to licensed dispensary owners and organic grow operators.
Wildflower Marijuana Inc. (CSE:SUN) is a cannabis company focused on developing and designing branded products in the marijuana sector. In this regard, Wildflower works exclusively in Washington State where such activity is permitted and regulated by State law, through entities which hold licenses for such activities. Further, Wildflower is advancing two applications to grow and distribute medical marijuana under an MMPR license with Health Canada. Wildflower's proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC cannabis for patients and cannabinoid research.
Zoned Properties Inc (OTC:ZDPY) is a strategic real estate development firm whose primary mission is to identify, develop, and lease sophisticated, safe, and sustainable properties in emerging industries, including the licensed marijuana industry. The Company acquires commercial properties that face unique zoning challenges and identifies solutions that can potentially have a major impact on the cash flow and value generated. Zoned Properties, Inc. targets commercial properties that can be acquired and potentially re-zoned for specific purposes. Zoned Properties does not grow, harvest, sell or distribute cannabis or any substances regulated under United States law such as the Controlled Substances Act.
Zynerba Pharmaceuticals Inc. (NasdaqGM:ZYNE) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Zynerba is developing therapeutic candidates based on proprietary transdermal technologies that, if successfully developed, may allow sustained, consistent and controlled delivery of therapeutic levels of two cannabinoids: cannabidiol (CBD), a non-psychoactive cannabinoid, and tetrahydrocannabinol (THC). Transdermal delivery has the potential to reduce adverse effects associated with oral dosing. ZYN002, the Company's CBD gel, is the first and only synthetic CBD formulated as a patent protected permeation-enhanced gel. In June 2016, the company initiated the Phase 2 STAR1 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial of ZYN002 CBD gel in adult refractory epilepsy patients with focal seizures and has also launched the STAR2 open-label extension trial which allows patients who complete STAR1 to receive treatment with ZYN002 gel for up to 52 weeks. In August 2016, the Phase 2 STOP (Synthetic Transdermal Cannabidiol for the Treatment of Knee Pain due to Osteoarthritis) clinical trial in patients with knee pain due to OA was initiated. A Phase 2 clinical trial in Fragile X syndrome (FXS) is expected to initiate in the second half of 2016. Zynerba is also developing ZYN001, which utilizes a synthetically manufactured pro-drug of THC. A Phase 1 clinical trial for ZYN001 is planned to begin in the first half of 2017.
Get the full list as a member at the Cannabis Directory page: http://www.investorideas.com/Marijuana-Stocks/Stocks_List.asp
This directory is for research purposes and not a solicitation to buy or sell securities.
To be added to the directory or update your description, please call or email us.
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.
Sectors we cover in include tech, bitcoin and blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow stocks in your favourite stock sector including marijuana and hemp stocks with Investor Ideas stock directories
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.